|Sensitivity||< 39 pg/mL|
|Standard Curve Range||39.06 pg/mL-2500 pg/mL|
|Assay Time||3 hr 20 min|
|Suitable Sample Type||For the quantitative determination the residue of nuclease in biologicals.|
|Sample volume||100 μL|
|CRS016-C01||Pre-coated Anti-Nuclease Antibody Microplate||1 plate|
|CRS016-C02||Nuclease Standard||50 μL|
|CRS016-C03||Biotin-Anti-Nuclease Antibody||100 μL|
|CRS016-C05||10xWashing Buffer||50 mL|
|CRS016-C06||2xDilution Buffer||50 mL|
|CRS016-C07||Substrate Solution||12 mL|
|CRS016-C08||Stop Solution||7 mL|
The GENIUS™ELISA Kit was developed for the detection and quantitative determination of nuclease in samples from downstream processing where nuclease is used as a process or purification aid.
The limitation of detectable dose (LOD) of Cat. No. CRS-A016 was determined as 2.733 pg/mL.
It is for research use only.
Find the expiration date on the outside packaging and do not use reagents past their expiration date.
The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
The kit shipped at room temperature that had been validated. Please contact us if you need blue ice shipping, but additional freight may be followed.
Below is the Shipping Statement for Kit Products.
Your experiment will include 6 simple steps:
a) All reagents were returned to room temperature(20°C-25°C) before use.
b) Add your sample to the plate, take the Nuclease as standard sample. The samples and standard sample are diluted by Dilution Buffer.
c) Add a diluted Biotin-Anti-Nuclease Antibody to the plate. The diluted by Dilution Buffer.
d) Wash the plate and add a diluted Streptavidin-HRP to the plate. The diluted by Dilution Buffer.
e) Wash the plate and add TMB.
f) Stop the substrate reaction by add diluted acid. Absorbance (OD) is calculate as the absorbance at 450 nm minus the absorbance at 630 nm to remove background prior to statistical analysis. The OD Value reflects the amount of protein bound.
For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.
GENIUS™ Nuclease ELISA Kit (Residue Testing) (Cat. No. CRS-A016) can detect the nuclease from different manufacturers with similar sensitivity.
GENIUS™ Nuclease ELISA Kit (Residue Testing) (Cat. No. CRS-A016) can detect the nuclease in different culture supernatant with similar curve and sensitivity.
GENIUS™ Nuclease ELISA Kit (Residue Testing) (Cat. No. CRS-A016) can detect the nuclease from different culture supernatant and was free from the matrix effects. * means a significant difference compared with the negative, NS means no significant difference with the negative.
Intra-Assay Precision : Twenty replicates of each of three samples containing different concentrations were tested in one assay. Within the detection range, the CV is less than 10%.
Inter-Assay Precision : Three replicates of each of three samples containing different concentrations were tested in three independent assays. Within the detection range, the CV is less than 10%.
Three parts of blank medium were added with three different concentrations of Nuclease, and the medium without Nuclease was used as background to calculate the recovery rate.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Price(EUR) : €660.00
ACROBiosystems offers a wide selection of Matrigengel basement membrane extracts. Different versions – including phenol red-free, high concentration, iPSC culturing, organoid culturing – are all available for your specific needs to support 3D cell culture!
ComboX is a new brand of ACROBiosystems. ComboX products include our Streptavidin series products, coated plates, isotype controls for antibody and fusion protein drug research, and general-purpose antibodies.
To enable antibody characterization methodsACROBiosystems has developed a series of enzymes.such as ldeS, SpeB, EndoH, and Endo S proteases, toassist with the characterization of antibodies and theirrelated post-translational modifications (PTMs)
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2， CD133, GPRC5D，CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro is ACROBiosystems brand focused on neuroscience research, providing high-quality important proteins including therapeutic and diagnostic research proteins, PFFs and recombinant neuro factors, etc. to advance neuroscience research.
|English Name||Research Code||Research Phase||Company||First Brand Name||First Approved Country||First Indication||First Approved Company||First Approved Fecha||Indications||Clinical Trials|
|English Name||Research Code||Research Phase||Company||Indications||Clinical Trials|
This web search service is supported by Google Inc.